Advertisement

Reactions Weekly

, Volume 1636, Issue 1, pp 47–47 | Cite as

Asunaprevir/daclatasvir

Pyrexia: case report
Case report

Reference

  1. Sato A, et al. Sustained virological response after a 17-day treatment with daclatasvir plus asunaprevir in a cirrhotic patient with hepatitis C virus genotype 1b and null response for peginterferon ribavirin therapy. Clinical Journal of Gastroenterology 9: 89-92, No. 2, Apr 2016. Available from: URL: http://doi.org/10.1007/s12328-016-0630-2 - Japan

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations